Skip to main content

Table 3 Effect of mRNA expression levels of ERBB4 and stage on DRFS (multivariate analysis, Cox-regression)

From: Prognostic value of ERBB4 expression in patients with triple negative breast cancer

Clinical variables HR 95% CI p-value
(A) All stages    
Stage    <0.001
 I 1.0 NA  
 IIA 1.37 0.47 – 4.01  
 IIB 3.28 1.07 – 10.04  
 IIIA 4.81 1.39 – 16.65  
 IIIC 35.12 9.62 – 128.27  
ERBB4 (median: 1.3)    0.005
 Low 1.0 NA  
 High 3.12 1.42 – 6.87  
(B) Early stage (N = 149)    
Stage    0.669
 I 1.0 NA  
 IIA 1.37 0.43 – 3.77  
ERBB4 (median: 1.3)    0.728
 Low 1.0 NA  
 High 1.21 0.41 – 3.55  
(C) Advanced stage (N = 54)    
Stage    <0.001
 IIB 1.0 NA  
 IIIA 1.12 0.33 – 3.83  
 IIIC 35.71 6.73 – 189.65  
ERBB4 (median: 1.3)    0.004
 Low 1.0 NA  
 High 7.79 1.96 – 31.01